Table 5 OTTA expansion cohort SATB2 and PAX8 expression by histotype
Histotype | SATB2 | PAX8 | SATB2/PAX8 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Absent, n (%) | Focal, n (%) | Diffuse, n (%) | absent, n (%) | Focal, n (%) | Diffuse, n (%) | SATB2-/PAX8 + n (%) | SATB2-/PAX8- n (%) | SATB2 + /PAX8 + n (%) | SATB2 + /PAX8- n (%) | |
MC | 159 | 137 (86%) | 11 (7%) | 11 (7%) | 97 (61%) | 40 (25%) | 22 (14%) | 59 (37%) | 78 (49%) | 3 (2%) | 19 (12%) |
MBOT | 46 | 44 (96%) | 0 (0%) | 2 (4%) | 23 (50%) | 17 (37%) | 6 (13%) | 23 (50%) | 21 (46%) | 0 (0%) | 2 (4%) |
EC | 515 | 439 (85%) | 67 (13%) | 9 (2%) | 92 (18%) | 148 (29%) | 275 (53%) | 364 (71%) | 75 (15%) | 59 (11%) | 17 (3%) |
CCC | 386 | 371 (96%) | 12 (3%) | 3 (1%) | 21 (5%) | 29 (8%) | 336 (87%) | 351 (91%) | 20 (5%) | 14 (4%) | 1 (0%) |
HGSC | 1698 | 1623 (96%) | 69 (4%) | 6 (0%) | 80 (5%) | 156 (9%) | 1462 (86%) | 1553 (91%) | 70 (4%) | 65 (4%) | 10 (1%) |
LGSC | 72 | 67 (93%) | 5 (7%) | 0 (0%) | 9 (13%) | 4 (6%) | 59 (82%) | 58 (81%) | 9 (13%) | 5 (7%) | 0 (0%) |
